5AM Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Rallybio, LLCrallybio.comin𝕏NASDAQ: RLYBApr 2024
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Steve Uden(Co-Founder & Chief Executive Officer)Stephen Uden(Founder)inMartin(Co-Founder & Chairman)Jon(Chief Financial Officer)
Board seatKush M ParmarPaula Soteropoulos· per SEC Form D
Co-investorsCanaan PartnersConnecticut InnovationsF-Prime CapitalMitsui Global InvestmentSolasta Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.